CD38 | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Statue of Perseus holding Medusa's head

Conferences Trial results

22 November 2023

ASH 2023 preview – Darzalex gets a first-line boost from Perseus

But, with the end in sight for the CD38 blockbuster, will Johnson & Johnson buy into Genmab’s next-gen project?

Subscribe to CD38